
USFDA APPLICATION NUMBER - 20862 / DOSAGE - CAPSULE;ORAL - 2.5MCG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DOXERCALCIFEROL(UNII: 3DIZ9LF5Y9) (doxercalciferol - UNII:3DIZ9LF5Y9) | DOXERCALCIFEROL | 1ug | 2.5ug | 0.5ug |
Inactive Ingredients
| Ingredient Name | American Health Packaging | Avera McKennan Hospital | Genzyme Corporation | Prasco Laboratories | REMEDYREPACK INC. | Winthrop U.S, a business of sanofi-aventis U.S. LLC |
|---|---|---|---|---|---|---|
| ALCOHOL(3K9958V90M) | ||||||
| AMMONIA(5138Q19F1X) | ||||||
| BUTYL ALCOHOL(8PJ61P6TS3) | ||||||
| BUTYLATED HYDROXYANISOLE(REK4960K2U) | ||||||
| COCONUT OIL(Q9L0O73W7L) | ||||||
| D&C YELLOW NO. 10(35SW5USQ3G) | ||||||
| FD&C RED NO. 40(WZB9127XOA) | ||||||
| FD&C YELLOW NO. 6(H77VEI93A8) | ||||||
| FERRIC OXIDE YELLOW(EX438O2MRT) | ||||||
| FERROSOFERRIC OXIDE(XM0M87F357) | ||||||
| GELATIN(2G86QN327L) | ||||||
| GELATIN, UNSPECIFIED(2G86QN327L) | ||||||
| GLYCERIN(PDC6A3C0OX) | ||||||
| ISOPROPYL ALCOHOL(ND2M416302) | ||||||
| MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U) | ||||||
| PROPYLENE GLYCOL(6DC9Q167V3) | ||||||
| SHELLAC(46N107B71O) | ||||||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||||||
| WATER(059QF0KO0R) |